54 related articles for article (PubMed ID: 30093354)
1. 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer.
Kizy S; Altman AM; Marmor S; Denbo JW; Jensen EH; Tuttle TM; Hui JYC
J Geriatr Oncol; 2019 Mar; 10(2):322-329. PubMed ID: 30093354
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis.
Zhou P; Zhang WW; Bao Y; Wang J; Lian CL; He ZY; Wu SG
Breast; 2020 Dec; 54():319-327. PubMed ID: 33278648
[TBL] [Abstract][Full Text] [Related]
3. Genomic expression assay testing among American Indian and Alaska Native women with breast cancer.
Marmor S; Longacre CF; Altman AM; Hui JYC; Jensen EH; Tuttle TM
Cancer; 2020 Dec; 126(24):5222-5229. PubMed ID: 32926435
[TBL] [Abstract][Full Text] [Related]
4. Differential distribution of actual and surrogate oncotype DX recurrence scores in breast cancer patients by age, menopausal status, race, and body mass index.
Mohamed A; Olsson LT; Geradts J
Breast Cancer Res Treat; 2023 Oct; 201(3):447-460. PubMed ID: 37453958
[TBL] [Abstract][Full Text] [Related]
5. Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
O'Neill SC; Isaacs C; Lynce F; Graham DM; Chao C; Sheppard VB; Zhou Y; Liu C; Selvam N; Schwartz MD; Potosky AL
Breast Cancer Res; 2017 Mar; 19(1):45. PubMed ID: 28359319
[TBL] [Abstract][Full Text] [Related]
6. The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients.
Li Y; Kurian AW; Bondarenko I; Taylor JMG; Jagsi R; Ward KC; Hamilton AS; Katz SJ; Hofer TP
Breast Cancer Res Treat; 2017 Feb; 161(3):587-595. PubMed ID: 28012085
[TBL] [Abstract][Full Text] [Related]
7. Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy.
Evans CN; Brewer NT; Vadaparampil ST; Boisvert M; Ottaviano Y; Lee MC; Isaacs C; Schwartz MD; O'Neill SC
Breast Cancer Res Treat; 2016 Apr; 156(3):549-555. PubMed ID: 27059031
[TBL] [Abstract][Full Text] [Related]
8. Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
Higgins T; Kantor O; Harrison B; Giordano J; McGrath M; Burstein HJ; Schnitt SJ; Rahman T; Vora H; Garrido-Castro A; Tolaney SM; Meric-Bernstam F; King TA; Mittendorf EA
Ann Surg Oncol; 2024 Apr; 31(4):2244-2252. PubMed ID: 38161200
[TBL] [Abstract][Full Text] [Related]
9. Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.
Afghahi A; Mathur M; Thompson CA; Mitani A; Rigdon J; Desai M; Yu PP; de Bruin MA; Seto T; Olson C; Kenkare P; Gomez SL; Das AK; Luft HS; Sledge GW; Sing AP; Kurian AW
J Oncol Pract; 2016 Jun; 12(6):e697-709. PubMed ID: 27221993
[TBL] [Abstract][Full Text] [Related]
10. Who gets genomic testing for breast cancer recurrence risk?
DeFrank JT; Salz T; Reeder-Hayes K; Brewer NT
Public Health Genomics; 2013; 16(5):215-22. PubMed ID: 23899493
[TBL] [Abstract][Full Text] [Related]
11. Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer.
Yang SP; Liu K; Li Y; Li GQ; Li JY; Lin YY; Wu SG
Expert Rev Mol Diagn; 2024; 24(1-2):99-106. PubMed ID: 38166613
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.
Stemmer SM; Steiner M; Rizel S; Soussan-Gutman L; Ben-Baruch N; Bareket-Samish A; Geffen DB; Nisenbaum B; Isaacs K; Fried G; Rosengarten O; Uziely B; Svedman C; McCullough D; Maddala T; Klang SH; Zidan J; Ryvo L; Kaufman B; Evron E; Karminsky N; Goldberg H; Shak S; Liebermann N
NPJ Breast Cancer; 2017; 3():33. PubMed ID: 28900633
[TBL] [Abstract][Full Text] [Related]
13. Relative survival of patients with supratentorial low-grade gliomas.
Smoll NR; Gautschi OP; Schatlo B; Schaller K; Weber DC
Neuro Oncol; 2012 Aug; 14(8):1062-9. PubMed ID: 22773277
[TBL] [Abstract][Full Text] [Related]
14. The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients.
Li L; Yu J; Shen K; Chen X
J Breast Cancer; 2024 Apr; ():. PubMed ID: 38769684
[TBL] [Abstract][Full Text] [Related]
15. Understanding how breast cancer patients use risk information from genomic tests.
DeFrank JT; Carey LA; Brewer NT
J Behav Med; 2013 Dec; 36(6):567-73. PubMed ID: 22878783
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of genomic signatures in young breast cancer patients: a systematic review.
Villarreal-Garza C; Ferrigno AS; De la Garza-Ramos C; Barragan-Carrillo R; Lambertini M; Azim HA
NPJ Breast Cancer; 2020; 6():46. PubMed ID: 33062888
[TBL] [Abstract][Full Text] [Related]
17. Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence Score.
Ha R; Chang P; Mutasa S; Karcich J; Goodman S; Blum E; Kalinsky K; Liu MZ; Jambawalikar S
J Magn Reson Imaging; 2019 Feb; 49(2):518-524. PubMed ID: 30129697
[TBL] [Abstract][Full Text] [Related]
18. Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Lu HM; Li S; Black MH; Lee S; Hoiness R; Wu S; Mu W; Huether R; Chen J; Sridhar S; Tian Y; McFarland R; Dolinsky J; Tippin Davis B; Mexal S; Dunlop C; Elliott A
JAMA Oncol; 2019 Jan; 5(1):51-57. PubMed ID: 30128536
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.
Tadros AB; Wen HY; Morrow M
Ann Surg Oncol; 2018 Oct; 25(11):3158-3164. PubMed ID: 30094484
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Li J; Wen WX; Eklund M; Kvist A; Eriksson M; Christensen HN; Torstensson A; Bajalica-Lagercrantz S; Dunning AM; Decker B; Allen J; Luccarini C; Pooley K; Simard J; Dorling L; Easton DF; Teo SH; Hall P; Borg Å; Grönberg H; Czene K
Int J Cancer; 2019 Mar; 144(5):1195-1204. PubMed ID: 30175445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
